Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.

Somoskovi A, Salfinger M.

Clin Lab Med. 2014 Jun;34(2):271-95. doi: 10.1016/j.cll.2014.03.001. Review.

PMID:
24856528
2.

[Atypical mycobacteria and pulmonary involvement in infectious diseases].

Camarena Miñana JJ, Pellicer RG.

Enferm Infecc Microbiol Clin. 2011 Dec;29 Suppl 5:66-75. doi: 10.1016/S0213-005X(11)70046-5. Spanish.

PMID:
22305672
3.

[Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].

Andréjak C, Lescure FX, Schmit JL, Jounieaux V.

Rev Mal Respir. 2011 Dec;28(10):1293-309. doi: 10.1016/j.rmr.2011.02.016. Epub 2011 Nov 8. French.

PMID:
22152937
4.

Evaluation of a membrane array for detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in positive liquid cultures.

Lu PL, Lin YC, Yang YC, Jou R, Huang SC, Jenh YS, Huang HH, Chang TC.

Diagn Microbiol Infect Dis. 2013 Apr;75(4):337-41. doi: 10.1016/j.diagmicrobio.2013.01.009.

PMID:
23514755
5.

Nontuberculous mycobacteria in respiratory tract infections, eastern Asia.

Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, van Soolingen D.

Emerg Infect Dis. 2011 Mar;17(3):343-9. doi: 10.3201/eid1703.100604. Review.

6.

Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.

van Ingen J, Boeree MJ, van Soolingen D, Mouton JW.

Drug Resist Updat. 2012 Jun;15(3):149-61. doi: 10.1016/j.drup.2012.04.001. Epub 2012 Apr 21. Review.

PMID:
22525524
7.

Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme.

Dholakia YN, Shah DP.

Indian J Chest Dis Allied Sci. 2015 Jan-Mar;57(1):27-30.

PMID:
26410980
8.

Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.

Hwang SM, Lim MS, Hong YJ, Kim TS, Park KU, Song J, Lee JH, Kim EC.

Tuberculosis (Edinb). 2013 Nov;93(6):642-6. doi: 10.1016/j.tube.2013.07.007. Epub 2013 Aug 7.

PMID:
23988279
9.

Management of nontuberculous mycobacterial (NTM) lung disease.

Philley JV, Griffith DE.

Semin Respir Crit Care Med. 2013 Feb;34(1):135-42. doi: 10.1055/s-0033-1333575. Epub 2013 Mar 4.

PMID:
23460013
10.

Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous Mycobacteria.

Lee MR, Cheng A, Huang YT, Liu CY, Chung KP, Wang HC, Liang SK, Liao CH, Yu CJ, Hsueh PR.

J Clin Microbiol. 2012 Oct;50(10):3398-401. doi: 10.1128/JCM.01862-12. Epub 2012 Aug 1.

11.

A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.

Lyu J, Kim BJ, Kim BJ, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS.

Respir Med. 2014 Nov;108(11):1706-12. doi: 10.1016/j.rmed.2014.09.002. Epub 2014 Sep 16.

12.

Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.

Gitti Z, Mantadakis E, Maraki S, Samonis G.

Future Microbiol. 2011 Sep;6(9):1099-109. doi: 10.2217/fmb.11.91.

PMID:
21958147
13.

Laboratory aspects of clinically significant rapidly growing mycobacteria.

Set R, Shastri J.

Indian J Med Microbiol. 2011 Oct-Dec;29(4):343-52. doi: 10.4103/0255-0857.90157. Review.

14.

Distribution of nontuberculous mycobacteria by multigene sequence-based typing and clinical significance of isolated strains.

Jang MA, Koh WJ, Huh HJ, Kim SY, Jeon K, Ki CS, Lee NY.

J Clin Microbiol. 2014 Apr;52(4):1207-12. doi: 10.1128/JCM.03053-13. Epub 2014 Feb 5.

15.

Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.

Guglielmetti L, Mougari F, Lopes A, Raskine L, Cambau E.

Future Microbiol. 2015;10(9):1467-83. doi: 10.2217/fmb.15.64. Epub 2015 Sep 7. Review.

PMID:
26344005
16.

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.

Qvist T, Pressler T, Høiby N, Katzenstein TL.

Respir Res. 2014 Apr 11;15:41. doi: 10.1186/1465-9921-15-41.

18.

Medications and monitoring in nontuberculous mycobacteria infections.

Egelund EF, Fennelly KP, Peloquin CA.

Clin Chest Med. 2015 Mar;36(1):55-66. doi: 10.1016/j.ccm.2014.11.001. Epub 2014 Dec 18. Review.

PMID:
25676519
19.

Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA.

Simmon KE, Brown-Elliott BA, Ridge PG, Durtschi JD, Mann LB, Slechta ES, Steigerwalt AG, Moser BD, Whitney AM, Brown JM, Voelkerding KV, McGowan KL, Reilly AF, Kirn TJ, Butler WR, Edelstein PH, Wallace RJ Jr, Petti CA.

Emerg Infect Dis. 2011 Sep;17(9):1692-700. doi: 10.3201/eid1709.101667.

20.

Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.

Li G, Pang H, Guo Q, Huang M, Tan Y, Li C, Wei J, Xia Y, Jiang Y, Zhao X, Liu H, Zhao LL, Liu Z, Xu D, Wan K.

Int J Antimicrob Agents. 2017 Mar;49(3):364-374. doi: 10.1016/j.ijantimicag.2016.10.024. Epub 2016 Dec 21.

PMID:
28131606

Supplemental Content

Support Center